HGF mimetic is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-09. Numbers and descriptions here follow the published literature rather than marketing material.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
== Structural studies == As of late 2007, 6 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1DO8, PDB: 1EFK, PDB: 1EFL, PDB: 1GZ3, PDB: 1LLQ, PDB: 1O0S, PDB: 1PJ2, PDB: 1PJ3, PDB: 1PJ4, PDB: 1PJL, PDB: 1QR6, PDB: 1WW8, and PDB: 2DVM.
===== Excavata ===== Leishmania tarentolae (cannot infect mammals) expression systems allow stable and lasting production of proteins at high yield, in chemically defined media. Produced proteins exhibit fully eukaryotic post-translational modifications, including glycosylation and disulfide bond formation.
==== Analysis of archaeologic materials ==== The GC-EI-MS has been used for the study and characterization of organic material present in coatings on Roman and Egyptian amphorae. From this analysis scientists found that the material used to waterproof the amphorae was a particular type of resin not native to the archaeological site but imported from another region. One disadvantage of this method was the long analysis time and requirement of wet chemical pre-treatment.
== Disease and serpinopathies == Serpins are involved in a wide array of physiological functions, and so mutations in genes encoding them can cause a range of diseases. Mutations that change the activity, specificity or aggregation properties of serpins all affect how they function. The majority of serpin-related diseases are the result of serpin polymerisation into aggregates, though several other types of disease-linked mutations also occur. The disorder alpha-1 antitrypsin deficiency is one of the most common hereditary diseases.
Analytes that are totally excluded, elute with the free volume outside around the particles (Vo), the total exclusion limit, while analytes that are completely delayed, elute with the solvent, marking the total permeation volume of the column, including also the solvent held inside the pores (Vi). The total volume can be considered by the following equation, where Vg is the volume of the polymer gel and Vt is the total volume:
Sources: en.wikipedia.org
=== Acting roles === Flay had a cameo appearance in the Disney Channel original movie Eddie's Million Dollar Cook-Off as the host of the cook-off. He appeared on the television game show Pyramid with fellow Iron Chef Mario Batali as the guest celebrities in an episode originally airing on November 18, 2003. He appeared as a judge on the CBS television show "Wickedly Perfect" during the 2004–05 season. He also appeared in the Law & Order: Special Victims Unit episode "Design", which originally aired on September 22, 2005. He had a small role as himself in the 2006 film East Broadway, in which his then-wife, Stephanie March, had a larger role. Jeopardy! featured a special "Throwdown with Bobby Flay" category during the March 12, 2008, episode, in which each of the clues featured Flay. He participated in the 2008 Taco Bell All-Star Legends and Celebrity Softball Game played at Yankee Stadium after the 2008 MLB All Star Game; Flay played for the National League. Flay is mentioned in the 2008 film Step Brothers in the "Derek comes for dinner" scene. In 2010, Flay was impersonated in the South Park cartoon episode "Crème Fraiche". In 2011, Flay had recurring appearances in the final season of Entourage as the boyfriend of Ari Gold's wife. In 2012, Flay appeared on Portlandia in a director's cut of the episode Brunch Village in which he showed director Jonathan Krisel how to make marionberry pancakes. Flay guest stars as himself on season two of the TV series Younger, which initially aired in 2016.
==== Insulin pump ==== An insulin pump delivers insulin subcutaneously. The insulin pump body itself can also contain the algorithm used in an AID system, or it can connect via Bluetooth with a separate mobile device (such as a phone) to send data and receive commands to adjust insulin delivery. Algorithm The algorithm for each AID system differs. In commercial systems (see below), little is known about the details of how the control algorithm works. In open source systems, the code and algorithm are openly available. In general, all algorithms do the same basic functionality of taking in CGM data and based on predicted glucose level's and the user's personal settings (for basal rates, insulin sensitivity, and carbohydrate ratio, for example) then recommends insulin dosing to help bring or maintain glucose levels in target range. Depending on the system, users may have the ability to adjust the target for the system, and may have different settings to ask the system to give more or less insulin in general.
=== Performance === The theme that structures the novel is that of performance. As the book opens, Kaname is gently pressuring his wife, Misako, into meeting her father and his mistress at a bunraku performance. The "old man" (he is fifty-six or fifty-seven) has a deep interest in many forms of traditional Japanese performance, from samisen and song to rustic puppets. But these are only the framing performances, as the life being led by Kaname and Misako is itself a performance, as Tanizaki reminds us several times. Even their son, Hiroshi, becomes a performer. The closing words of the novel transform a wooden doll into a woman. In many ways, from local accent to clothing, the central characters assume roles they need and can hardly bear, making the story a series of mirrors in which artifice and reality become interwoven.
== Fluorescence == The chain catshark is one of four elasmobranch species shown to possesses biofluorescent properties. The researchers of the study examined the vision of Scyliorhinus retifer using microspectrophotometry and designed a "shark-eye" camera that yielded contrast information on areas where fluorescence is anatomically distributed on the shark. The repeated evolution of biofluorescence in elasmobranchs, coupled with a visual adaptation to detect it; and evidence that biofluorescence creates greater luminosity contrast with the surrounding background, highlights the potential importance of biofluorescence in elasmobranch behavior and biology. The key fluorescent pigments in the chain catshark and the swell shark are a set of brominated kynurenine compounds that appear to be synthesized by the kynurenine pathway starting from 6-bromo-tryptophan. The biochemical origin of 6-bromo-tryptophan in these species is not known.
Sources: en.wikipedia.org
== Figurative uses == The use of the word "juice" to mean "liquor" (alcohol) dates from 1828. The use of the term "juice" to mean "electricity" dates from 1896. As a verb, the word "juice" was first recorded as meaning "to enliven" in 1964. The adjective "juiced" is recorded as meaning "drunk" in 1946 and "enhanced or as if enhanced by steroids" in 2003. The adjective "juicy" has meant "succulent" since the 15th century (e.g., a juicy roast beef). The figurative meaning "wealthy, full of some desired quality" dates from the 1620s (e.g., a pirate calling a heavily laden ship he aims to plunder a "juicy catch"). The meaning "lively, suggestive, racy, sensational" (e.g., a juicy scandal) is from 1883.
According to Osborne, the game's maps had "imaginative texturing and dramatic lighting effects", but pointed out that they were too dark sometimes. Wolfe felt that the environmental textures were realistic enough. Critics appreciated the realistic weapon sound effects, with Osborne writing that they made guns "viscerally fun to shoot". Wolfe agreed, but wished "the same amount of attention to detail was given to the rest of the sound in the game". He felt that the crashing thunder was flat and pointed out that footsteps didn't vary based on the surface being walked on. Dodson felt that the animations were dated, but were "nothing to scoff at". Hiles commented that the character model animations needed improvement.
==== Kerogens and coals ==== The first stage that sedimentary organic matter (SOM) experiences after deposition is diagenesis. During diagenesis, biological decomposition can alter the DHR of organics. Several experimental studies have shown that some biodegraded materials become slightly enriched in D (less than 50‰). Most organics become kerogen by the end of diagenesis. Generally, δD of kerogen spans a wide range. Many factors contribute to the kerogen we observe in geologic records, including:
When the PSOE took office the Spanish economy was in full expansion. One of the factors that had made this possible was the arrival of several million emigrants from Latin America, the Maghreb and Eastern Europe. But part of them were "undocumented" migrants so the government decided to proceed with a massive "regularization" throughout 2005 that affected about 700 000 people who obtained a residence permit by presenting a contract of employment. The PP accused the government of provoking a "call effect" of new emigrants. The integration of the four million emigrants who had arrived in Spain in the last 10 years – so that foreigners now accounted for almost 10% of the population – posed an enormous challenge for Spanish society. The main "engine" of economic growth was being the construction sector, driven by increased demand. However, much of it was the result of a speculative movement around the "brick" as many people did not buy the homes to inhabit them but to place their savings hoping to sell them later at a higher price. This was how the "Spanish property bubble" was fed. But in the summer of 2007, the outbreak of the subprime mortgage crisis in the United States had an immediate repercussion in Europe and especially in Spain, where housing prices stopped rising, the construction sector came to a standstill and this dragged down the economy as a whole which began to grow at a slower pace with the consequent increase in unemployment.
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin, bilirubin (direct and indirect), and others. The liver transaminases aspartate transaminase (AST or SGOT) and alanine transaminase (ALT or SGPT) are useful biomarkers of liver injury in a patient with some degree of intact liver function. Most liver diseases cause only mild symptoms initially, but these diseases must be detected early. Hepatic (liver) involvement in some diseases can be of crucial importance. This testing is performed on a patient's blood sample. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase and alkaline phosphatase). Because some of these tests do not measure function, it is more accurate to call these liver chemistries or liver tests rather than liver function tests. Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease. They can help distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.